Du verden @grib1, her var det mye spennede å lære om potensialet i Vaccibodys Covid vaksine!
Det virker som Adaptive ser på Vaccibodys vaksine som en universell booster vaksine!
Markedet er mao potensielt helt gigantisk!
“If our partner Vaccibody shows that their vaccine, which is a DNA-based vaccine that doesn’t have kind of the cold chain storage requirements proves to be effective on a stand-alone or as a universal booster, that would be a tremendous upside case”
"OK. And then congrats on the Vaccibody deal. I guess a quick three-part question. The first, I think I heard you say that this would be used as a universal booster.
Would that be, obviously, a booster for both Moderna and Pfizer? Or can you comment on that? And then secondly, I would imagine this is likely a non-exclusive deal. Can you confirm that? And then on the royalty side, should we think of this as like a low-single digit? Or could it be more lucrative than that?
Chad Robins – Chief Executive Officer and Co-Founder
Yes. So, I’m going to try to make sure I got those all in, Mark. But – the first question is – the answer is yes. We do see this as a potential universal booster."
" But also the one thing that’s unique about Vaccibody is their ability to target the immune response directly to the antigen presenting cells of choice. So as far as we know, this is – as far as I’m aware, this is a unique ability"
Mulig vi har årsaken til siste dagers kraftige oppgang her.
